Goldberg, S., Ahmed, N., & Gazelle, G
However, it is important to note that mean ALT and aspartate aminotransferase (AST) levels remained stable or even decreased by the end of the 48-week treatment period
So the same pharmaceutical company makes a pure insulin product (Toujeo), a combination insulin-plus-GLP-1 product (Soliqua), and markets them through similar channels to similar patient populations
The right choice ultimately depends on your goals, individual response and how well you tolerate side effects, something best discussed with your provider to find the most suitable option
GLP-1s are contraindicated in some thyroid cancers
MOTS-C + GHK-Cu GHK-Cu drives cellular regeneration, collagen synthesis, and anti-inflammatory signaling